secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001654954-25-006811
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA posts updated investor presentation reflecting new business strategy announced March 31, 2025
--------------------------------------------------------------------------------

- Filed under Item 7.01; presentation posted on company website without new financial or operational data.
- No new material facts disclosed; presentation references previously announced strategy shift.
- Filing contains only procedural language; investor gains no actionable information from this 8-K alone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000165495425006811/0001654954-25-006811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000165495425006811/endra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-006811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer